5Y capital
5Y seeks $700m for latest China VC fund
China-focused 5Y Capital has set a target of USD 700m for its latest venture capital fund – in line with what the manager raised in the previous vintage.
China's Keep raises $40m in Hong Kong IPO
Keep, a China-focused fitness app operator backed by the likes of GGV Capital, SoftBank Vision Fund 2, and 5Y Capital, traded up slightly on debut after raising HKD 313.5m (USD 40m) in a smaller-than-anticipated Hong Kong IPO.
Meituan to buy Chinese AGI player Light Year
Listed Chinese consumer technology platform Meituan has agreed to acquire 100% of Light Year, a VC-backed local artificial general intelligence (AGI) business, for USD 284.3m.
China edtech player Nowcoder raises $50m
Beijing-based Nowcoder Technology, a Chinese campus recruitment platform also known as Niuke, has raised USD 50m in Series B funding from Sequoia Capital China, Shunwei Capital, 5Y Capital, Tiger Global Management, and Pegasus Capital.
China's Moore Threads closes $218m Series B
Moore Threads, a China-based designer of artificial intelligence (AI) chips, has raised CNY 1.5bn (USD 218m) in Series B funding led by China Mobile Digital New Economy Industry Fund and Hexie Health Insurance, with participation from Dianshi Capital.
2023 preview: Hard-tech
As China’s technology space has shifted toward more advanced domains of R&D, bubbles have formed and geopolitics have complicated investment. There is scope for some turnaround on these points
China fitness app Keep pursues Hong Kong listing
Keep, a China-focused fitness app operator backed by the likes of GGV Capital, SoftBank Vision Fund 2, and 5Y Capital, has filed for a Hong Kong IPO.
Prosperity7 backs China-founded unstructured data specialist Zilliz
Prosperity7 Ventures, a venture capital fund established by Saudi Arabia state oil giant Saudi Aramco, has led a USD 60m Series B extension for China-founded open-source software developer Zilliz.
India fintech player Cred closes $140m Series F
Cred, an India-based credit card rewards provider, has closed a USD 140m Series F round that includes a secondary component intended to facilitate exits for existing investors.
China biotech: End of the boom
PE investment in China biotech has collapsed amid failed IPO processes and disputed valuations. Pockets of activity remain, though questions around commercialisation have yet to be answered
AstraZeneca-CICC fund backs China gene sequencer
Axbio, a China-based provider of gene sequencing and diagnostic systems, has raised nearly USD 100m in Series B funding led by AstraZeneca-CICC Healthcare Industrial Fund and Yunfeng Capital.
5Y leads $74m round for China AI drug developer
Beijing-based HeliXon, an artificial intelligence-enabled developer of protein-based drugs, has raised CNY 500m (USD 75m) in Series A funding led by 5Y Capital. Other investors include Gaorong Capital and Neumann Capital.
Capital Today leads $40m Series B for China's XYZ Robotics
XYZ Robotics, a Chinese start-up specialising in robotic hand-eye coordination, has raised an extended Series B round of USD 40m led by Capital Today China Group.
Capital Today leads $100m round for China's Hai Robotics
Hai Robotics, a China-based warehouse robot company, has raised an extended Series D round of USD100m led by Capital Today China Group.
Ince leads $30m round for China’s PhiGent Robotics
Beijing-based autonomous driving solutions provider PhiGent Robotics has raised a USD30m Series A round led by Ince Capital. Previous investors such as Atypical Ventures, 5Y Capital, and GSR Ventures re-upped.
China's Sensors Data raises $200m
Chinese marketing technology provider Sensors Data has raised a USD 200m Series D round led by Tiger Global Management and The Carlyle Group.
China's VisionNav Robotics raises $80m
5Y Capital and Meituan, China’s leading online-to-offline services provider, have led a USD 80m Series C extension for VisionNav Robotics, a local manufacturer of driverless industrial vehicles.
China's METiS Pharmaceuticals raises $150m
METiS Pharmaceuticals, a Hangzhou-based drug formulation company has raised USD 150m through two funding rounds led by PICC Capital and China Life PE.
China 3D content platform Xverse raises $120m
Xverse, a Shenzhen-based 3D user-generated content platform has raised USD 120m across a Series A and a Series A extension, led by GL Ventures and Sequoia Capital China, respectively.
AVCJ Awards 2021: Fundraising of the Year - Venture Capital: 5Y Capital
5Y Capital’s history encompasses early bets on change across mobile internet, smart cars, and biotech in China. The VC firm remains committed to challenging consensus views
China AI gaming company Parametrix raises $100m
Chinese artificial intelligence (AI) gaming company Parametrix.ai has raised a USD 100m Series B round led by Sequoia Capital China. Existing investors 5Y Capital and Gaorong Capital re-upped.
2022 preview: China fundraising
Investors held fire on commitments to China managers amid uncertainty over regulatory reforms. Industry participants hope the government will provide clarity, but the fear LPs won’t hurry back
Vision Fund joins $300m round for China vaccine developer
SoftBank Vision Fund 2 and 5Y Capital have led a $300 million Series C extension for Suzhou Abogen Biosciences, a Chinese vaccine developer focused on mRNA products, including one for COVID-19.